Cases 1 - 10 of 26
HDI Global SE et al v. FMC Corporation
as 1:2024cv00878
Plaintiff:
Vienna Insurance Group, Swiss Re International SE, QBE Europe SA/NV and others
Defendant:
FMC Corporation
Cause Of Action: 28 U.S.C. § 1332 Diversity-Property Damage
Hematite RE I, Inc. et al v. Angstrom Fiber Englewood, LLC et al
as 1:2024cv00334
Counter Defendant:
Hematite RE I, Inc. and Woodbridge Englewood, Inc.
Defendant:
Angstrom Fiber Englewood, LLC and Angstrom Automotive Group, LLC
Cause Of Action: 28 U.S.C. § 1330 Breach of Contract
OmniVision Technologies, Inc. v. RE Secured Networks, LLC
as 1:2024cv00187
Plaintiff:
OmniVision Technologies, Inc.
Defendant:
RE Secured Networks, LLC
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Ebury Street Capital, LLC et al v. McOsker et al
as 1:2021cv00203
Plaintiff:
Ebury Fund 2 NJ, LLC, Ebury Street Capital, LLC, EB 2EMIALA, LLC and others
Defendant:
Andrew Kernan, LienClear, LLC, LienClear 0002, LLC and others
3Rd Party Defendant:
Lesser Flamingo LLC, John Bronzo, Ping Xie and others
Cause Of Action: 28 U.S.C. § 1331 Fed. Question: Breach of Contract
Rosenblatt v. Jernigan Capital, Inc. et al
as 1:2020cv01141
Defendant:
NexPoint Re Merger, Inc., Jernigan Capital, Inc., Howard A. Silver and others
Plaintiff:
Jordan Rosenblatt
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re: Auryxia (Ferric Citrate) Patent Litigation
as 1:2019md02896
Not Classified By Court:
Chemo Research S.L., Insud Pharma S.L., Teva Pharmaceuticals USA, Inc. and others
Counter Defendant:
Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc. and Chen Hsing Hsu
Counter Claimant:
Lupin Atlantis Holdings SA and Lupin Ltd.
In Re:
In re: Auryxia (Ferric Citrate) Patent Litigation
Cause Of Action: 35 U.S.C. § 271
In re: Sensipar (Cinacalcet Hydrochloride Tablets) Antitrust Litigation
as 1:2019md02895
Not Classified By Court:
UFCW Local 1500 Welfare Fund, Actavis Pharma Inc., Cipla Ltd. and others
Plaintiff:
Cesar Castillo, Inc. and KPH HEALTHCARE SERVICES, INC.
In Re:
In re: Sensipar (Cinacalcet Hydrochloride Tablets) Antitrust Litigation
Cause Of Action: 15 U.S.C. § 1
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
